Alpha Cognition (NASDAQ:ACOG – Get Free Report) posted its earnings results on Monday. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.48) by ($0.03), Zacks reports.
Alpha Cognition Stock Down 8.5 %
Shares of ACOG stock opened at $5.06 on Tuesday. The firm has a market cap of $81.06 million, a P/E ratio of -1.98 and a beta of 2.50. The company has a 50-day moving average price of $5.83. Alpha Cognition has a twelve month low of $4.66 and a twelve month high of $7.00.
Wall Street Analyst Weigh In
Several research firms have recently commented on ACOG. Raymond James upgraded shares of Alpha Cognition to a “moderate buy” rating in a research report on Tuesday, March 25th. HC Wainwright reiterated a “buy” rating and set a $20.00 target price on shares of Alpha Cognition in a report on Monday.
About Alpha Cognition
Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Read More
- Five stocks we like better than Alpha Cognition
- Stock Analyst Ratings and Canadian Analyst Ratings
- Palantir Stock Builds Momentum on New Partnership
- Short Selling – The Pros and Cons
- Tech Sell-Off Makes Microsoft Stock Look Like a Steal
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Is Now the Right Time to Invest in a Natural Gas ETF?
Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
